PerpEquities

Arm Holdings plc (ARM) financials

NASDAQ · Technology · Semiconductors · 9,584 employees · CEO Rene Anthony Andrada Haas

Price
$205.97 -9.97%
Market cap
$219B
Enterprise value
$217B
Last report
Q1 '27 filed 2026-07-29
Next report
2026-11-04 EPS est. $0.48
Revenue (TTM)$5.16B+25.1% vs a year agoLast 4 quarters; bars = each quarter
Operating margin (TTM)17.3%-1.0 pp vs a year agoOperating income $892M
Net income (TTM)$1.04B+49.4% vs a year agoAfter tax, incl. non-operating gains
Free cash flow (TTM)$1.47B+124.4% vs a year agoCapex $620M
Diluted EPS (TTM)$0.97+47.0% vs a year agoSum of the last 4 quarters
Net cash$3.4B+35.6% vs a year agoCash + short-term investments - debt

Valuation & key figures

Market cap
$219B
EV $217B
Revenue
$5.16B
Trailing 12 months
Revenue growth
+24%
FY2027 consensus
Profit margin
20.2%
Net income / revenue, TTM
P/E
212.3×
Forward 93.4× (FY2027)
P/S
42.5×
Price / sales, TTM
EV / EBITDA
157.7×
TTM
Free cash flow
$1.47B
Trailing 12 months
Net income
$1.04B
Trailing 12 months
Revenue estimate
$6.09B
FY2027 consensus
Earnings
2026-11-04
Revenue est. $1.38B
Dividend
–
No dividend

Key takeaways

Computed from the reported numbers - every statement carries the figure it rests on.

  • Last report (2026-07-29): revenue beat by 2.1%, EPS beat by 12.5%Revenue $1.29B vs $1.26B expected (+2.1%); EPS $0.45 vs $0.40 (+12.5%).
  • Revenue growth steady: 22.4% year on yearQ1 '27 revenue $1.29B, against an average of 23.3% over the four quarters before.
  • Operating margin 17.3% (TTM), -1.0 pp on a year agoOperating income grew 18.0% while revenue grew 25.1%.
  • 29.4% of pre-tax profit is non-operatingPre-tax income $1.26B vs operating income $892M (TTM). Gains on equity stakes and other one-off items lift net income and EPS - operating income is the cleaner measure of the business.
  • Capex 12.0% of revenue (a year ago 8.8%)$620M invested in the last 4 quarters (+71.3% on a year earlier). Free cash flow $1.47B = 141.2% of net income.
  • Returned $202M to shareholders = 13.7% of free cash flowBuybacks $202M (a year earlier $85M), dividends $0, stock-based pay $1.15B (TTM).
  • Diluted share count up 1.2% in a year1.08B diluted shares in Q1 '27, 1.07B a year earlier.
  • Net cash $3.4BCash + short-term investments $3.89B, debt incl. leases $485M; a year ago net cash $2.51B.

Last quarter: Q1 '27

Quarter ended 2026-06-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.

Quarter vs a year ago

Q1 '27Year agoChange
Revenue$1.29B$1.05B+22.4%
Gross margin97.2%94.3%+2.9 pp
Operating income$98M$107M-8.4%
Operating margin7.6%10.2%-2.6 pp
Net income$270M$130M+107.7%
Diluted EPS$0.25$0.12+108.3%
Operating cash flow$902M$332M+171.7%
Capex$208M$161M+29.2%
Free cash flow$694M$171M+305.8%
R&D$838M$654M+28.1%
Stock-based compensation$343M$241M+42.3%

Reported vs consensus

2026-07-29
ActualConsensusvs consensus
Revenue$1.29B$1.26B+2.1%
EPS (as estimated)$0.45$0.40+12.5%

From the report of 2026-07-29 for Q1 '27: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.

EPS vs consensus

last 8 reports

Revenue

Where the money comes from - by business line and by region, quarter by quarter.

Revenue, operating income and growth

quarterly

Margins & cost structure

How much of each unit of revenue is left at each level - and where the costs go.

Margins

quarterly

Costs as % of revenue

quarterly

Cash flow & capital allocation

Cash generated, what it is spent on, and what reaches shareholders.

Operating cash flow, capex, free cash flow

quarterly

Uses of cash vs operating cash flow

fiscal years

Last 4 quarters

cash flow statement
Operating cash flow
$2.09B
Capex
-$620M
Buybacks
-$202M
Dividends
$0
Acquisitions
$45M
Net debt issued
$0
Stock-based compensation
$1.15B
Free cash flow
$1.47B
Returned to shareholders / FCF
13.7%

Share count and EPS

quarterly, diluted

Balance sheet

Liquidity, investments and debt at each quarter end.

Cash, investments and debt

quarter ends

Valuation & returns

Today's multiples against the company's own last five fiscal years; analyst targets and ratings.

Multiples and returns

TTM vs 5 fiscal years
Now5y averageWhere today sits in the 5-year range
P/E (TTM)212.3×195.0×112.5× – 423.0×
EV / EBITDA157.7×162.9× 4 of 5 years72.5× – 344.1×
EV / Sales42.0×30.6× 4 of 5 years22.8× – 39.8×
Price / FCF148.7×238.2×96.5× – 629.9×
Price / Book25.4×18.9× 4 of 5 years15.4× – 24.6×
FCF yield0.7%0.6%0.2% – 1.0%
Return on invested capital7.3%5.7%0.0% – 10.3%
Return on equity13.0%8.2%0.0% – 12.9%

Analysts

Consensus target $375.92 (+82.5%)
range $250.00 – $641.00 · rating Buy

Strong buy0
Buy19
Hold6
Sell2
Strong sell0

Outlook

Analyst consensus for the coming fiscal years and what it implies at today's price.

Consensus estimates

Fiscal yearRevenueGrowthEPSGrowthP/E at today's priceAnalysts (EPS)
FY2027$6.09B+23.8%$2.21+159.4%93.4×19
FY2028$8.3B+36.4%$3.02+37.0%68.2×24
FY2029$10.8B+30.3%$3.92+29.8%52.5×11
FY2030$16.4B+51.5%$6.34+61.9%32.5×11
FY2031$27.3B+66.6%$10.05+58.4%20.5×18

Financial statements

Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.

Sources

Statements, segment revenue, metrics and estimates: Financial Modeling Prep.

Data as of 2026-11-01